Now we talkin. These funds will likely see CHM to prelim results in the Core-NK with Vactosertib and CHD-17 into the clinic.
An extra $10m we didnt have access to 3 hours ago. Good to see Paul Hopper and management putting their hands in their pocket and backing the assets.
Ann: CHM secures up to A$12.6m through SPP and placements, page-3
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CHM (ASX) Chart |
Day chart unavailable